FDLI Committees

As a membership organization, we depend on the dedication and commitment of our committee volunteers to enhance Institute activity. FDLI committees consist of volunteer members who provide expertise regarding conferences, publications and other actions.

Our volunteer committees include editorial advisory boards and product sector committees (e.g., Drugs and Biologics). Each January, we invite our membership to volunteer to serve on these groups (committee appointments are made in the first quarter of the same year). Committee terms, typically three years in duration, begin and conclude in April. New, standing, and outgoing committee members are invited to participate at ‘committee day’ held the day before FDLI’s Annual Conference each Spring in Washington, DC.

If you are a member and interested in serving, email Customer Service to be considered.

Academic Programs Committee 
Audit Committee 
Austern Writing Awards Committee - Long Papers 
Austern Writing Awards Committee - Short Papers 
Board of Directors 
Drugs and Biologics Committee 
Editorial Advisory Board (Journal) 
Editorial Advisory Board (Primer) 
Editorial Advisory Board (Policy Forum) 
Editorial Advisory Board (Update) 
Executive Committee  
Finance Committee 
Food and Dietary Supplements Committee
Global Committee
Medical Devices Committee 
Tobacco Committee 


Academic Program Committee

The Academic Programs Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI's mission, relating to programs and publications of interest to the academic legal community. The Committee discusses various programs, publications, pricing, dissemination vehicles, etc. that best facilitate expanding FDLI's educational mission.

  • Marie Boyd (Vice-Chair) University of South Carolina
  • Jess Amchin (Committee Member) Drexel University
  • Katlin McKelvie Backfield (Committee Member) FDA - OC
  • Harvey Alan Berman (Committee Member) State University of NY at Buffalo
  • Laurie J. Beyranevand (Committee Member) Vermont Law School
  • Bianca Buechner (Committee Member) IU Center for Bioethics
  • Sarah diFrancesca (Committee Member) Cooley LLP
  • Barbara Evans PhD, JD (Committee Member) University of Houston
  • Arnold I. Friede (Committee Member) University of Miami
  • Ralph F. Hall (Committee Member) University of Minnesota
  • Joseph A. Page (Committee Member) Georgetown University
  • Herman M. Rhee Ph.D. (Committee Member) Sole Practitioner
  • Stuart TenHoor (Committee Member) Stuart TenHoor Legal Search
  • Roseann B. Termini JD, MEd (Committee Member) Widener University School of Law
  • Ralph S. Tyler (Committee Member) Venable LLP
  • Seth B Whitelaw (Committee Member) Sole Practitioner
Back to Top

Audit Committee

  • Barbara A. Binzak Blumenfeld PhD, JD (Chair) Buchanan Ingersoll & Rooney PC
  • Karen M. Becker (Committee Member) Precision for Medicine
  • Jennifer L. Bragg (Committee Member) Skadden, Arps, Slate, Meagher & Flom LLP
  • Freddy A. Jimenez (At-Large) Johnson & Johnson
  • William H. Kitchens (At-Large) Arnall Golden Gregory LLP
Back to Top

Austern Writing Awards Committee - Long Papers

The H. Thomas Austern Writing Awards Committee assists FDLI staff in determining the award recipient(s) for the best student papers submitted for publication. Members of the Committee (with subcommittees for long and short papers) develop publicity for and promote the competition, and subsequently review all submitted student manuscripts, determining which are most appropriate for awards and/or publication.

  • Colleen M. Heisey (First Vice Chair) JONES DAY
  • Albert F. Cacozza (Committee Member) Ropes & Gray LLP
  • Igor Gorlach (Committee Member) Foley Hoag LLP
  • Natasha V. Leskovsek (Committee Member) Cooley LLP
  • Patrick O'Leary (Committee Member) Sidley Austin LLP
  • Gail L. Pilgrim (Committee Member) Temple University
  • Matthew Poliner (Committee Member) Venable LLP
Back to Top

Austern Writing Awards Committee - Short Papers

The H. Thomas Austern Writing Awards Committee assists FDLI staff in determining the award recipient(s) for the best student papers submitted for publication. Members of the Committee (with subcommittees for long and short papers) develop publicity for and promote the competition, and subsequently review all submitted student manuscripts, determining which are most appropriate for awards and/or publication.

  • James M. Flaherty Jr. (Chair) Fresenius Medical Care
  • Jonas Anderson (First Vice Chair) American University
  • Deborah C. Attwood (Committee Member) Steptoe & Johnson LLP
  • Sara Koblitz (Committee Member) Fish & Richardson P.C.
  • Elinor Hart Murarova (Committee Member) Duane Morris LLP
  • Margaret F. Riley (Committee Member) University of Virginia
  • Amy Rinaldo (Committee Member) Oakland Law Group, PLLC
Back to Top

Board of Directors

  • Sheila M. Hemeon-Heyer (Chair) Heyer Regulatory Solutions LLC
  • Allison M. Zieve JD (Vice-Chair) Public Citizen
  • Philip Katz (Immediate Past Chair) Hogan Lovells LLP
  • Patricia B. Shrader (Treasurer) Medtronic, Inc.
  • Jeffrey N. Gibbs (Secretary and General Counsel) Hyman, Phelps & McNamara, P.C.
  • Steven H. Armstrong (Committee Member) Campbell Soup Company
  • Frederick R. Ball (Committee Member) Duane Morris LLP
  • Barbara A. Binzak Blumenfeld PhD, JD (Committee Member) Buchanan Ingersoll & Rooney PC
  • Lewis A. Grossman PhD, JD (Committee Member) American University
  • Leslie T. Krasny (Committee Member) Keller and Heckman LLP
  • Joy J. Liu (Committee Member) Ropes & Gray LLP
  • Scott M. Melville (Committee Member) Consumer Healthcare Products Association (CHPA)
  • Carmen Shepard (Committee Member) Mylan Pharmaceuticals, Inc.
  • Peter E. Tamborski (Committee Member) Sugar Creek Packing Company
  • John Taylor (Committee Member) Greenleaf Health LLC
  • Amy Comstock Rick (President & CEO) FDLI
Back to Top

Drugs and Biologics Committee

The Drugs and Biologics Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI's mission, relating to programs and publications of interest to the drugs and biologics industries. The Committee advises staff on the appropriateness of conferences and publications relating to pharmaceuticals and biologics by reviewing and commenting on proposals.

  • Carolyn Alenci (Committee Member) Duane Morris LLP
  • Ilisa B.G. Bernstein PharmD.,JD (Committee Member) FDA - CDER
  • Cathy L. Burgess (Committee Member) Alston & Bird LLP
  • Rebecca Burnett (Committee Member) Mylan Pharmaceuticals, Inc.
  • Krista Hessler Carver (Committee Member) Covington & Burling LLP
  • David L. Chesney (Committee Member) PAREXEL Consulting
  • Diane L. Darvey (Committee Member) National Association of Chain Drug Stores
  • Maxine K. Fritz (Committee Member) NSF Health Sciences
  • John H. Fuson (Committee Member) Crowell & Moring LLP
  • William A. Garvin (Committee Member) Buchanan Ingersoll & Rooney PC
  • Todd H. Halpern (Committee Member) Pfizer, Inc.
  • Carolyn Herrmann (Committee Member) Consumer Healthcare Products Association (CHPA)
  • Matthew Hill (Committee Member) Novo Nordisk Inc.
  • Wanda E Hill (Committee Member) GlaxoSmithKline
  • Elizabeth R. Jungman (Committee Member) The Pew Charitable Trusts
  • Daniel A. Kracov (Committee Member) Arnold & Porter LLP
  • Erika F. Lietzan (Committee Member) University of Missouri-Columbia School of Law
  • Brian J. Malkin (Committee Member) McGuireWoods LLP
  • Christina M. Markus (Committee Member) King & Spalding LLP
  • Minnie Mildwoff (Committee Member) Novartis Vaccines & Diagnostics
  • George A O'Brien (Committee Member) Hogan Lovells LLP
  • Jeffrey Peters (Committee Member) MacroGenics Inc.
  • Kai Peters (Committee Member) Gordon & Rees LLP
  • Laura A. Rich (Committee Member) FDA - CTP
  • Lee Rosebush (Committee Member) Baker & Hostetler
  • David B. Schmickel JD, PhD (Committee Member) Fox Kiser
  • Angela M. Seaton (Committee Member) Shook, Hardy & Bacon L.L.P.
  • Sarah Spurgeon (Committee Member) PhRMA
  • Mason Weeda (Committee Member) Olsson Frank Weeda Terman Matz PC
  • Jason Sol Zielonka M.D. (Committee Member) Eli Lilly and Company
Back to Top

Journal Editorial Advisory Board

The Journal Editorial Advisory Board promotes the educational, scholarly, and other purposes of the Food and Drug Law Journal. Members of the Board serve as peer reviewers for papers submitted for publication and recommend topics for "special / symposia" issues.

  • Anthony Anscombe (Committee Member) Sedgwick LLP
  • Michael Bui (Committee Member) TEVA Pharmaceuticals USA, Inc.
  • Catherine A. Clements (Committee Member) Express Scripts, Inc.
  • Meredith Edwards Collins (Committee Member) Bass, Berry & Sims
  • Kellie B. Combs (Committee Member) Ropes & Gray LLP
  • Nathan G. Cortez (Committee Member) Southern Methodist University
  • Brian A. Dahl (Committee Member) Dahl Compliance Consulting LLC
  • Sandra DePaulis (Committee Member) FDA - CFSAN
  • Erin M. Duffy (Committee Member) Duane Morris LLP
  • Ian Fearon (Committee Member) British American Tobacco
  • Robert C. Giddings (Committee Member) Hutchinson PLLC
  • Abraham Gitterman (Committee Member) Arnold & Porter LLP
  • Kimberly J. Gold (Committee Member) Norton Rose Fulbright LLP
  • Peter Barton Hutt (Committee Member) Covington & Burling LLP
  • John Johnson (Committee Member) FDAImports.com, LLC
  • Alan C. Katz (Committee Member) toXcel, LLC
  • Laurie Lenkel (Committee Member) FDA - OC
  • Valerie Madamba (Committee Member) Bayer Corporation
  • Alan G. Minsk (Committee Member) Arnall Golden Gregory LLP
  • Nicole Negowetti (Committee Member) Valparaiso University
  • Francis B. Palumbo PhD (Committee Member) University of Maryland School of Pharmacy
  • Sandra Retzky (Committee Member) Johns Hopkins University
  • Joan R. Rothenberg (Committee Member) FDA - CFSAN
  • Jodi Schipper (Committee Member) FDA - CDER
  • Jennifer Schwartz (Committee Member) Covington & Burling LLP
  • Christopher Gail Van Gundy (Committee Member) Keller and Heckman LLP
  • Kimberly F. Yocum (Committee Member) Johnson & Johnson/McNeil Consumer Healthcare
  • Patricia Zettler (Committee Member) Georgia State University
Back to Top

Primer Editorial Advisory Board

  • Sharon M. Bradley (Committee Member) Hunton & Williams LLP
  • Tina Hu-Rodgers (Committee Member) Buchanan Ingersoll & Rooney PC
  • Elizabeth F. Lindquist (Committee Member) King & Spalding LLP
  • Pam Marone (Committee Member) Toxicology and Pharmacology Inc.
  • Matthew Reed (Committee Member) Sedgwick LLP
  • Sarah Taylor Roller (Committee Member) Kelley Drye & Warren LLP
  • Marc C. Sanchez (Committee Member) Contract In-House Counsel & Consultants, LLC
  • Lance L. Shea MS (Committee Member) Baker & Hostetler
  • Karen Sie (Committee Member) Norton Rose Fulbright LLP
Back to Top

Policy Forum Editorial Board

  • Victoria W. Girard (Vice-Chair) Georgetown University
  • James A Boiani (Committee Member) Epstein Becker & Green, P.C.
  • Thomas Cluderay (Committee Member) Environmental Working Group
  • Lisa E. Davis (Committee Member) Quarles & Brady LLP
  • Jeffrey K. Francer (Committee Member) PhRMA
  • Jennifer J. Hillman Pharm.D (Committee Member) University Health System
  • Elizabeth Isbey (Committee Member) McDermott Will & Emery
  • Ralph F. Ives (Committee Member) AdvaMed
  • Beth A Krewson (Committee Member) Incyte Corporation Experimental Station
  • Marian J. Lee (Committee Member) Gibson Dunn & Crutcher LLP
  • Erik R. Lieberman (Committee Member) U.S. Food Imports LLC
  • Jonathan R. McKnight (Committee Member) FDA - CBER
  • Nicholas J. Nowakowski (Committee Member) Oakland Law Group, PLLC
  • Flora Chinyere Okereke (Committee Member) British American Tobacco
  • Megan L. Olsen (Committee Member) Kelley Drye & Warren LLP
  • Kirsten Paulson (Committee Member) Pfizer, Inc.
  • Christine Perez (Committee Member) American College of Cardiology
  • Mark I. Schwartz (Committee Member) FDA - CBER
  • Laura Sim (Committee Member) Covington & Burling LLP
  • David C. Spangler (Committee Member) Consumer Healthcare Products Association (CHPA)
  • Josephine M. Torrente (Committee Member) Hyman, Phelps & McNamara, P.C.
  • Alan Traettino (Committee Member) Stryker Corporation
  • Daron Watts (Committee Member) Sidley Austin LLP
  • Brian Joseph Wesoloski (Committee Member) Mylan Pharmaceuticals, Inc.
Back to Top

Update Editorial Advisory Board

The Update Editorial Advisory Board promotes the highest levels of professional, educational, and scholarly written commentary on timely issues of interest to professionals in the areas of foods, drugs, biologics, medical devices, other healthcare technologies, and cosmetics in FDLI's magazine The Board serves as a resource for FDLI staff to develop feature theme ideas, acquire articles of interest to readers, and advise on the magazine's quality and success in serving the interests and needs of its readers.

  • Joanne Hawana (Vice-Chair) Mintz, Levin, Cohn, Ferris, Glovskyand Popeo, P.C.
  • Jacqueline Chan (Committee Member) K&L Gates LLP
  • Bridget C.E. Dooling (Committee Member) Office of Management & Budget
  • Stacy L. Ehrlich (Committee Member) Kleinfeld, Kaplan & Becker, LLP
  • Hope S. Freiwald (Committee Member) Dechert LLP
  • Shelly Garg (Committee Member) Sandler, Travis & Rosenberg, P.A.
  • Lori F. Hirsch (Committee Member) Merck & Co., Inc.
  • Alissa Jijon (Committee Member) Keller and Heckman LLP
  • Kari K. Loeser (Committee Member) Jazz Pharmaceuticals, Inc.
  • Alexandra Marzelli (Committee Member) BD
  • Gary C. Messplay (Committee Member) Hunton & Williams LLP
  • Alagra Morris (Committee Member) Georgia State University
  • Jessica O'Connell (Committee Member) Covington & Burling LLP
  • Nneka C. Onwudiwe (Committee Member) FDA - CDER
  • Krasimira S Pekova (Committee Member) Northeastern University
  • Smitha G. Stansbury (Committee Member) King & Spalding LLP
Back to Top

Executive Committee

  • Sheila M. Hemeon-Heyer (Chair) Heyer Regulatory Solutions LLC
  • Allison M. Zieve JD (Vice-Chair) Public Citizen
  • Philip Katz (Immediate Past Chair) Hogan Lovells LLP
  • Patricia B. Shrader (Treasurer) Medtronic, Inc.
  • Jeffrey N. Gibbs (Secretary and General Counsel) Hyman, Phelps & McNamara, P.C.
  • Amy Comstock Rick (President & CEO) FDLI
Back to Top

Finance Committee

The purpose of the Finance Committee is to ensure the responsible financial operations of FDLI. The Committee provides on-going oversight of the financial operations and investment policies of FDLI to ensure sound financial management. The Committee also advises the Board on the direction and control of financial matters. The Committee also ensures that the Board is well informed about the Institute's finances.

  • Patricia B. Shrader (Chair) Medtronic, Inc.
  • Frederick R. Ball (Board Liaison) Duane Morris LLP
  • Don L. Bell II (At-Large) National Association of Chain Drug Stores
  • Kellie B. Combs (Committee Member) Ropes & Gray LLP
  • David M. Fox (Committee Member) Hogan Lovells LLP
Back to Top

Food and Dietary Supplements Committee

The Food and Dietary Supplements Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI's mission, relating to programs and publications of interest to the food and dietary supplement industries. The Committee advises staff on the appropriateness of conferences and publications relating to foods and dietary supplements by reviewing and commenting on proposals.

  • Rend Al-Mondhiry (Committee Member) Council for Responsible Nutrition
  • Stephanie K. Barnes (Committee Member) Food Marketing Institute
  • Sarah L. Brew (Committee Member) Faegre Baker Daniels LLP
  • Ricardo Carvajal (Committee Member) Hyman, Phelps & McNamara, P.C.
  • Carlos Celestino JD (Committee Member) U.S. Pharmacopeia
  • Judie Dziezak (Committee Member) Dziezak Law Firm, P.C.
  • Ted Elkin (Committee Member) FDA - CFSAN
  • Jennifer Erickson (Committee Member) FDA - CVM
  • Elizabeth Barr Fawell (Committee Member) Hogan Lovells LLP
  • Les Alan Glick (Committee Member) Porter Wright Morris & Arthur LLP
  • James Gorny (Committee Member) Produce Marketing Association
  • Karin A. Gregory (Committee Member) Furman Gregory Deptula LLC
  • Miriam J. Guggenheim (Committee Member) Covington & Burling LLP
  • Patricia Knight (Committee Member) Knight Capitol Consultants
  • Emilia Lonardo (Committee Member) Grocery Manufacturers Association
  • Chi-Hua Lu (Committee Member) Abbott Laboratories
  • Stuart M. Pape (Committee Member) Polsinelli PC
  • Justin R. Prochnow (Committee Member) Greenberg Traurig, LLP
  • Ronald Y. Rothstein (Committee Member) Winston & Strawn LLP
  • Brooke Schumm III (Committee Member) Daneker, McIntire, Schumm
  • Bruce A. Silverglade (Committee Member) Olsson Frank Weeda Terman Matz PC
  • Suzanne Loonam Trigg (Committee Member) Haynes and Boone, LLP
  • Andrew R. Varcoe (Committee Member) Biotechnology Industry Organization
Back to Top

Global Committee

The Global Committee advises FDLI staff on international conferences and domestic meetings with global content as well as publications marketed to an international audience. Its duties and responsibilities include advising staff on ongoing developments in specific countries and helping staff keep current on global legal, regulatory and policy issues. The committee includes one ex-officio member from the following committees and editorial advisory boards: Academic Programs, Food and Dietary Supplements, Medical Devices and Diagnostics, Drugs & Biologics, Update, Food and Drug Law Journal and Food and Drug Policy Forum as well as other at-large members.

  • David W. K. Acheson MD (Chair) The Acheson Group
  • Wade Ackerman (At-Large) Senate Committee on HELP
  • Philip S. Brewster (Committee Member) Brewster Law Firm LLC
  • Li Cai (At-Large) Pfizer, Inc.
  • James N. Czaban (Committee Member) Wiley Rein LLP
  • Jill M Daley (Committee Member) Norton Rose Fulbright LLP
  • Jennifer Devine (At-Large) U.S. Pharmacopeia
  • Patrick C. Gallagher (Committee Member) Duane Morris LLP
  • Robert Kozak (Committee Member) Bayer Corporation
  • Francine Lamoriello (Committee Member) Personal Care Products Council
  • Dorothy Linvill-Neal (At-Large) Novartis Pharmaceuticals Corporation
  • Jacqueline Mailly (Committee Member) Hogan Lovells LLP
  • Maureen E. McGirr (Committee Member) Merck & Co., Inc.
  • David C. Mitchell M.Sc. (At-Large) Aquinox Pharmaceuticals
  • Daniel Moelands (At-Large) Medtronic, Inc.
  • Jeff Nelligan (Committee Member) FDA - ORA
  • Peter Pitts (Committee Member) Center for Medicine in the Public Interest
  • Bob A. Rhoades (Committee Member) Quintiles Transnational Corporation
  • Fredric J. Richman (At-Large) Transnational Strategy Group
  • Eliana A. Silva de Moraes PhD (At-Large) Silva de Moraes Advogados Associados
  • James M. Solyst MS (Committee Member) Swedish Match North America
  • Denise Sturdy (Committee Member) Duke Clinical Research Institute
  • Sara Zborovski (At-Large) DLA Piper LLP
Back to Top

Medical Devices Committee

The Medical Devices Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI's mission, relating to programs and publications of interest to the Medical Devices industries. The Committee advises staff on the appropriateness of conferences and publications relating to medical devices by reviewing and commenting on proposals.

  • Paul Gadiock (Co-Chair) FDA - CDRH
  • Linda D. Bentley (Committee Member) Mintz, Levin, Cohn, Ferris, Glovskyand Popeo, P.C.
  • Michele L. Buenafe (Committee Member) Morgan, Lewis & Bockius LLP
  • David E. Chadwick PhD (Committee Member) Cook Group Incorporated
  • Michael E. Clark (Committee Member) Duane Morris LLP
  • Luz Idalia Collado (Committee Member) Hoffmann-La Roche, Inc.
  • Mark Dahlby (Committee Member) Hall Render Killian Heath & Lyman
  • Denise D. Dion (Committee Member) EduQuest, Inc.
  • David K. Elder (Committee Member) PAREXEL Consulting
  • Iris Rolander Gibbs (Committee Member) Regeneron Pharmaceuticals, Inc.
  • Sonali P. Gunawardhana (Committee Member) Wiley Rein LLP
  • Andrew S. Ittleman (Committee Member) Fuerst Ittleman David & Joseph, PL
  • Richard Kaeser (Committee Member) Johnson & Johnson Health Care Systems
  • Mark C. Levy (Committee Member) Eckert Seamans Cherin & Mellott, LLC
  • Carole E. Marcot Esq. (Committee Member) Sole Practitioner
  • Alexandra Marzelli (Committee Member) BD
  • Rebecca Jones McKnight (Committee Member) DLA Piper LLP
  • Maura Martin Norden (Committee Member) Greenleaf Health LLC
  • Vernessa T. Pollard (Committee Member) Arnold & Porter LLP
  • Marc J. Scheineson (Committee Member) Alston & Bird LLP
  • Jeffrey K. Shapiro (Committee Member) Hyman, Phelps & McNamara, P.C.
  • Lenita Sims (Committee Member) Abbott Laboratories
  • Nicole Taylor Smith (Committee Member) FDA - OC
  • Lynn C. Tyler (Committee Member) Barnes & Thornburg LLP
  • Marta L. Villarraga PhD (Committee Member) Exponent, Inc.
  • Kristi L. Wolff (Committee Member) Kelley Drye & Warren LLP
Back to Top

Tobacco Committee

The Tobacco Committee advises FDLI staff in formulating and implementing policies and strategies relating to programs and publications about law, regulation and policy affecting tobacco products. Duties and Responsibilities include advising staff on the appropriateness of conferences and publications relating to this topic area by suggesting topics and reviewing and commenting on proposals.

  • Azim Chowdhury (Committee Member) Keller and Heckman LLP
  • Stacy L. Ehrlich (Committee Member) Kleinfeld, Kaplan & Becker, LLP
  • Stacey Gagosian (Committee Member) American Legacy Foundation
  • Joseph Graham Gitchell (Committee Member) Pinney Associates, Inc.
  • Jonathan A. Havens (Committee Member) Venable LLP
  • Dennis Henigan (Committee Member) Campaign for Tobacco-Free Kids
  • Matthew Lyons (Committee Member) FDA - CBER
  • William A. McGrath (Committee Member) Potomac Law Group
  • Marina A Murphy (Committee Member) British American Tobacco
  • Mitchell A. Neuhauser (Committee Member) Reynolds American, Inc.
  • Taryn Fritz Walpole (Committee Member) Greenleaf Health LLC
  • Gregory Wilson (Committee Member) Altria Client Services, Inc.
Back to Top